tiprankstipranks
Rising High: Exclusive talk with biopharma company HMNC Brain Health
PremiumThe FlyRising High: Exclusive talk with biopharma company HMNC Brain Health
1M ago
Compass Pathways to be added to Nasdaq Biotechnology Index at open on 12/23
Premium
The Fly
Compass Pathways to be added to Nasdaq Biotechnology Index at open on 12/23
1M ago
Rising High: Organigram acquires Motif Labs for C$90M upfront
Premium
The Fly
Rising High: Organigram acquires Motif Labs for C$90M upfront
1M ago
Rising High: Exclusive talk with house of brands Carma HoldCo
PremiumThe FlyRising High: Exclusive talk with house of brands Carma HoldCo
3M ago
Compass Pathways price target lowered to $60 from $120 at H.C. Wainwright
Premium
The Fly
Compass Pathways price target lowered to $60 from $120 at H.C. Wainwright
3M ago
Compass Pathways cuts 30% of workforce on Phase 3 trial delays
Premium
The Fly
Compass Pathways cuts 30% of workforce on Phase 3 trial delays
3M ago
Rising High: Compass Pathways reports Q3 earnings
PremiumThe FlyRising High: Compass Pathways reports Q3 earnings
3M ago
Compass Pathways reports Q3 EPS (56c), consensus (57c)
Premium
The Fly
Compass Pathways reports Q3 EPS (56c), consensus (57c)
3M ago
Compass Pathways sees 2024 operating net cash use $114M-$120M
Premium
The Fly
Compass Pathways sees 2024 operating net cash use $114M-$120M
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100